Drugs Made In America Acquisition II Corp. (DMII)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-30
Fiscal PeriodQ4-FY2025Q3-FY2025
Close Price of Common Stock10.00$9.97$9.87$
Market Cap of Common Stock655,750,000$653,782,750$647,225,250$
QoQ%.30%1.01%
YoY%
Close Price of Warrant
Close Price of Unit10.04$10.02$9.94$
Close Price of Right0.08$0.14$
Common Shares Outstanding63,700,00013,700,00015,575,00014,375,00014,375,00014,375,00014,375,000
QoQ%(12.04%)8.35%.00%.00%.00%
YoY%343.13%(4.70%)8.35%